Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.

Source:http://linkedlifedata.com/resource/pubmed/id/15319676

J. Acquir. Immune Defic. Syndr. 2004 Sep 1 37 1 1160-5

Download in:

View as

General Info

PMID
15319676